Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-24 1:59 pm Purchase | 2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN | TCG Crossover Management LLC | 1,314,000 13.700% | 400,000 (+43.76%) | Filing History |
| 2021-09-23 4:31 pm Purchase | 2021-09-21 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 3,460,351 19.990% | 3,460,351 (New Position) | Filing History |
| 2021-09-10 06:03 am Purchase | 2021-09-01 | 13G | Viridian Therapeutics, Inc. VRDN | TCG Crossover Management LLC | 914,000 9.500% | 914,000 (New Position) | Filing History |
| 2021-08-26 12:56 pm Purchase | 2021-08-16 | 13G | Viridian Therapeutics, Inc. VRDN | Frazier Life Sciences Public Fund, L.P. | 1,305,200 13.600% | 1,305,200 (New Position) | Filing History |
| 2021-06-01 4:02 pm Purchase | 2021-05-20 | 13G | Viridian Therapeutics, Inc. VRDN | D. E. Shaw & Co., L.P. | 720,373 8.500% | 248,679 (+52.72%) | Filing History |
| 2021-05-10 4:04 pm Purchase | 2021-04-29 | 13G | Viridian Therapeutics, Inc. VRDN | D. E. Shaw & Co., L.P. | 471,694 6.500% | 471,694 (New Position) | Filing History |
| 2021-03-15 4:38 pm Purchase | 2021-03-10 | 13G | Viridian Therapeutics, Inc. VRDN | RA CAPITAL MANAGEMENT L.P. | 388,385 6.300% | 388,385 (New Position) | Filing History |
| 2021-03-10 07:17 am Purchase | 2021-02-26 | 13G | Viridian Therapeutics, Inc. VRDN | Wellington Management Group LLP | 578,560 11.100% | 578,560 (New Position) | Filing History |
| 2021-02-19 08:02 am Purchase | 2021-02-09 | 13G | Viridian Therapeutics, Inc. VRDN | Hawkes Bay Master Investors (Cayman) L.P. | 363,284 6.970% | 363,284 (New Position) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | MIRAGEN THERAPEUTICS INC MGEN | Citadel Advisors LLC | 427,218 9.900% | 656 (+0.15%) | Filing History |
| 2021-02-16 3:09 pm Purchase | 2020-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Point72 Asset Management, L.P. | 426,162 10.900% | 426,162 (New Position) | Filing History |
| 2021-01-19 4:18 pm Purchase | 2021-01-07 | 13G | MIRAGEN THERAPEUTICS INC MGEN | Cormorant Asset Management, LP | 459,144 9.990% | 459,144 (New Position) | Filing History |
| 2021-01-11 4:08 pm Purchase | 2020-12-31 | 13G | MIRAGEN THERAPEUTICS INC MGEN | Citadel Advisors LLC | 426,562 9.900% | 426,562 (New Position) | Filing History |
| 2021-01-11 12:07 pm Purchase | 2020-12-16 | 13G | MIRAGEN THERAPEUTICS INC MGEN | Xencor Inc XNCR | 322,407 7.600% | 322,407 (New Position) | Filing History |
| 2021-01-07 07:36 am Purchase | 2020-12-31 | 13G | MIRAGEN THERAPEUTICS INC MGEN | Ally Bridge MedAlpha Master Fund L.P. | 929,979 9.990% | 929,979 (New Position) | Filing History |
| 2021-01-05 06:04 am Purchase | 2021-12-31 | 13D | MIRAGEN THERAPEUTICS INC MGEN | Fairmount Funds Management LLC | 967,671 19.990% | 967,671 (New Position) | Filing History |